PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning. Rigorous science and careful analysis is critical to the success of everything we aspire to do. Our team, comprising of diverse employees with a wide range of backgrounds and experiences, is passionate about solving challenging problems and making a huge impact.
We're looking for a skilled and experienced translational scientist program manager to join our team and help support the execution of PathAI’s business and academic partnerships, including strategic projects, external collaborations and internal initiatives. The Translational Science Lead will work closely with machine learning, biomedical data sciences, product development, and business operations teams to ensure that our scientific project goals are being met, and that we and that we are maximizing our platform’s capabilities. The Translational Science Lead will be responsible for the day-to-day operations of current project relationships and supporting the development of new activities, as well as lead internal scientific strategy within disease areas.
What you’ll do:
What you’ll need:
For the right candidate, we'll offer a competitive salary plus equity. Your compensation is rounded out by a strong benefits package:
Most importantly, you'll be doing important work with a team of people you'll genuinely enjoy spending the day with.
PathAI is an equal opportunity employer, dedicated to creating a workplace that is free of harassment and discrimination. We base our employment decisions on business needs, job requirements, and qualifications — that's all. We do not discriminate based on race, gender, religion, health, personal beliefs, age, family or parental status, or any other status. We don't tolerate any kind of discrimination or bias, and we are looking for teammates who feel the same way.
PathAI does not accept unsolicited submissions from third-parties.